ENXTPA:ORPersonal Products
A Look At L'Oréal (ENXTPA:OR) Valuation After CeraVe Benzene Lawsuits Raise Product Safety Concerns
Multiple class action lawsuits targeting CeraVe acne products have thrust L'Oréal (ENXTPA:OR) into the spotlight, prompting investors to reassess product safety risks, potential legal liabilities, and how these might influence sentiment toward the stock.
See our latest analysis for L'Oréal.
Recent share price moves suggest sentiment is steady rather than surging, with a 1-day share price return of 1.24% and a 1-year total shareholder return of 0.40%. Multi year total shareholder returns...